ABSTRACT
Introduction Several factors should be taken into account before choosing and starting an anticancer treatment. They are related to the disease, the patient, and the impact of the treatment, but they are also related to society. When deciding on a treatment, all relevant tumor-related factors [e.g., histology, tumor characteristics (e.g., estrogen receptor, mutations)] and staging examinations should be available and discussed in a multidisciplinary staff meeting. All members of the multidisciplinary team should have their input in the treatment decision, which should be specific for the individual patient resulting from evidence-based or consensus-driven guidelines.
